250 related articles for article (PubMed ID: 21252248)
21. Elevated thrombin activatable fibrinolysis inhibitor levels in women with polycystic ovary syndrome.
Güldaş M; Altinkaya SÖ; Nergiz S; Demircan-Sezer S; Yüksel H
Gynecol Endocrinol; 2015 Jul; 31(7):536-9. PubMed ID: 26220768
[TBL] [Abstract][Full Text] [Related]
22. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
23. Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome.
Jedel E; Gustafson D; Waern M; Sverrisdottir YB; Landén M; Janson PO; Labrie F; Ohlsson C; Stener-Victorin E
Psychoneuroendocrinology; 2011 Nov; 36(10):1470-9. PubMed ID: 21549510
[TBL] [Abstract][Full Text] [Related]
24. Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome.
Sales MF; Sóter MO; Candido AL; Fernandes AP; Oliveira FR; Ferreira AC; Sousa MO; Ferreira CN; Gomes KB
Gynecol Endocrinol; 2013 Oct; 29(10):936-9. PubMed ID: 23898913
[TBL] [Abstract][Full Text] [Related]
25. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
26. The plasminogen activator system in young and lean women with polycystic ovary syndrome.
Tarkun I; Cantürk Z; Arslan BC; Türemen E; Tarkun P
Endocr J; 2004 Oct; 51(5):467-72. PubMed ID: 15516780
[TBL] [Abstract][Full Text] [Related]
27. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
28. Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome.
Glueck CJ; Iyengar S; Goldenberg N; Smith LS; Wang P
J Lab Clin Med; 2003 Jul; 142(1):35-45. PubMed ID: 12878984
[TBL] [Abstract][Full Text] [Related]
29. Hemostatic and metabolic variables in women with polycystic ovary syndrome.
Dahlgren E; Janson PO; Johansson S; Lapidus L; Lindstedt G; Tengborn L
Fertil Steril; 1994 Mar; 61(3):455-60. PubMed ID: 8137966
[TBL] [Abstract][Full Text] [Related]
30. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
[TBL] [Abstract][Full Text] [Related]
31. Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome.
Carmassi F; De Negri F; Fioriti R; De Giorgi A; Giannarelli C; Fruzzetti F; Pedrinelli R; Dell'Omo G; Bersi C
Thromb Res; 2005; 116(3):207-14. PubMed ID: 15935829
[TBL] [Abstract][Full Text] [Related]
32. Dynamic variability of hemostatic and fibrinolytic factors in young women.
Giardina EG; Chen HJ; Sciacca RR; Rabbani LE
J Clin Endocrinol Metab; 2004 Dec; 89(12):6179-84. PubMed ID: 15579775
[TBL] [Abstract][Full Text] [Related]
33. Increased Coagulation and Decreased Fibrinolysis as Measured with Overall Hemostatic Potential Are Dependent on BMI and Not Associated with PCOS.
Rakusa M; Jensterle M; Božič-Mijovski M; Janez A
Metab Syndr Relat Disord; 2017 May; 15(4):194-198. PubMed ID: 28287900
[TBL] [Abstract][Full Text] [Related]
34. Circulating high-sensitivity C-reactive protein and soluble CD40 ligand are inter-related in a cohort of women with polycystic ovary syndrome.
El-Mesallamy HO; Abd El-Razek RS; El-Refaie TA
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):178-82. PubMed ID: 23434327
[TBL] [Abstract][Full Text] [Related]
35. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.
Ehrmann DA; Schneider DJ; Sobel BE; Cavaghan MK; Imperial J; Rosenfield RL; Polonsky KS
J Clin Endocrinol Metab; 1997 Jul; 82(7):2108-16. PubMed ID: 9215280
[TBL] [Abstract][Full Text] [Related]
36. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome.
Lauria PB; Del Puerto HL; Reis AM; Candido AL; Reis FM
J Clin Endocrinol Metab; 2013 Dec; 98(12):4882-9. PubMed ID: 24057296
[TBL] [Abstract][Full Text] [Related]
37. Hypoadiponectinemia: a useful marker of dyslipidemia in women with polycystic ovary syndrome.
Chang CY; Chen MJ; Yang WS; Yeh CY; Ho HN; Chen SU; Yang YS
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):583-90. PubMed ID: 23276562
[TBL] [Abstract][Full Text] [Related]
38. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
[TBL] [Abstract][Full Text] [Related]
39. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
40. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.
Carmina E; Campagna AM; Lobo RA
Hum Reprod; 2013 Aug; 28(8):2245-52. PubMed ID: 23595974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
